Ubs Group Ag Abbott Laboratories Call Options Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$100.07 - $118.13 $34.3 Million - $40.4 Million
342,300 Added 61.98%
894,577 $102 Million
Q2 2024

Aug 13, 2024
BUY
$100.73 - $112.44 $2.68 Million - $2.99 Million
26,620 Added 5.06%
552,277 $57.4 Million
Q1 2024

May 13, 2024
SELL
$109.52 - $120.96 $1.51 Million - $1.66 Million
-13,753 Reduced 2.55%
525,657 $59.7 Million
Q4 2023

Feb 09, 2024
BUY
$90.19 - $110.4 $30.6 Million - $37.5 Million
339,510 Added 169.84%
539,410 $59.4 Million
Q3 2023

Nov 09, 2023
SELL
$95.53 - $114.62 $5.53 Million - $6.64 Million
-57,900 Reduced 22.46%
199,900 $19.4 Million
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $12.3 Million - $13.7 Million
122,000 Added 89.84%
257,800 $28.1 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $4.38 Million - $5.15 Million
45,200 Added 49.89%
135,800 $13.8 Million
Q4 2022

Feb 08, 2023
SELL
$95.06 - $111.52 $11.3 Million - $13.2 Million
-118,600 Reduced 56.69%
90,600 $9.95 Million
Q3 2022

Nov 10, 2022
BUY
$96.76 - $112.03 $20.2 Million - $23.4 Million
209,200 New
209,200 $20.2 Million
Q1 2022

May 16, 2022
SELL
$114.02 - $139.04 $20.8 Million - $25.4 Million
-182,600 Reduced 85.01%
32,200 $3.81 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $12 Million - $14.7 Million
103,667 Added 93.28%
214,800 $30.2 Million
Q2 2021

Aug 13, 2021
SELL
$105.79 - $124.53 $423,160 - $498,120
-4,000 Reduced 3.47%
111,133 $12.9 Million
Q1 2021

May 12, 2021
BUY
$108.84 - $128.23 $2.62 Million - $3.08 Million
24,033 Added 26.38%
115,133 $13.8 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $5.95 Million - $6.49 Million
56,700 Added 164.83%
91,100 $9.98 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $1.83 Million - $2.23 Million
-20,000 Reduced 36.76%
34,400 $3.74 Million
Q2 2020

Jul 31, 2020
SELL
$76.57 - $98.0 $1.58 Million - $2.02 Million
-20,600 Reduced 27.47%
54,400 $4.97 Million
Q1 2020

May 01, 2020
SELL
$62.82 - $91.86 $6.94 Million - $10.1 Million
-110,400 Reduced 59.55%
75,000 $5.92 Million
Q4 2019

Feb 14, 2020
BUY
$78.51 - $87.4 $3.56 Million - $3.97 Million
45,400 Added 32.43%
185,400 $16.1 Million
Q3 2019

Nov 14, 2019
BUY
$81.84 - $88.74 $7.37 Million - $7.99 Million
90,000 Added 180.0%
140,000 $11.7 Million
Q1 2019

May 14, 2019
BUY
$66.22 - $80.06 $1.5 Million - $1.82 Million
22,700 Added 83.15%
50,000 $4 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $802,692 - $968,352
-13,200 Reduced 32.59%
27,300 $2 Million
Q1 2018

May 15, 2018
BUY
$56.27 - $63.62 $1.29 Million - $1.46 Million
22,900 Added 130.11%
40,500 $2.43 Million
Q4 2017

Feb 14, 2018
BUY
$53.68 - $57.47 $944,768 - $1.01 Million
17,600
17,600 $1 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email